Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 14
Submit an article Journal homepage
187
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

UK national audit of extracorporeal photopheresis (ECP) in chronic graft versus host disease

Francesca A. M. KinsellaUK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UKCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6022-2567
ORCID Icon,
Alvin BencitoUK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK
,
Daniela KulikUK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK
,
Erin HurstUK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK
,
Maria GilleeceUK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK
,
John A. SnowdenUK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK
,
Ram MalladiUK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK
,
Julia ScarisbrickUK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK
,
Andrew GenneryUK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK
&
Arun AlfredUK Photopheresis Society, Birmingham, Rotherham, Newcastle, Leeds, Sheffield, UK
 show all
Pages 3511-3514 | Received 01 Jun 2020, Accepted 14 Aug 2020, Published online: 02 Sep 2020

References

  • Socie G, Ritz J. Current issues in chronic graft-versus-host disease. Blood. 2014;124(3):374–384.
  • Arai S, Arora M, Wang T, et al. Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2015;21(2):266–274.
  • Styczyński J, Tridello G, Koster L, Infectious Diseases Working Party EBMT, et al. Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors. Bone Marrow Transplant. 2020;55(1):126–136.
  • Dignan FL, Amrolia P, Clark A, British Society for Blood and Marrow Transplantation, et al. Diagnosis and management of chronic graft-versus-host disease. Br J Haematol. 2012a;158(1):46–61.
  • Alfred A, Taylor PC, Dignan F, et al. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society. Br J Haematol. 2017;177(2):287–310.
  • Carreras E, Dufour C, Mohty M, et al., editors. The EBMT handbook. Cham: Springer; 2019.
  • Couriel DR, Hosing C, Saliba R, et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood. 2006;107(8):3074–3080.
  • Dignan FL, Greenblatt D, Cox M, et al. Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. Bone Marrow Transplant. 2012b;47(6):824–830.
  • Foss FM, DiVenuti GM, Chin K, et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant. 2005;35(12):1187–1193.
  • Flowers MED, Apperley JF, van Besien K, et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood. 2008;112(7):2667–2674.
  • Greinix HT, van Besien K, Elmaagacli AH, et al. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis–results of a crossover randomized study. Biol Blood Marrow Transplant. 2011;17(12):1775–1782.
  • Greinix HT, Volc-Platzer B, Rabitsch W, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998;92(9):3098–3104.
  • Specialised Commisioning Team NHS England. Clinical Commissioning Policy: treatments for graft versus host disease following haematopoieitc stem cell transplantation. [cited 2020 Aug 25]. Available from: https://www.england.nhs.uk/publication/treatments-for-graft-versus-host-disease-gvhd-following-haematopoietic/.
  • Jagasia M, Scheid C, Socie G, et al. Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD. Blood Adv. 2019;3(14):2218–2229.
  • Paczesney S. Biomarkers for post-transplantation outcomes. Blood. 2018;131(20):2193–2204.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.